1. OC-0563 First experience with the model-based selection of head and neck cancer patients for proton therapy. (April 2019) Authors: Tambas, M.; Van der Laan, H.P.; Van den Hoek, J.G.M.; Bijl, H.P.; Dieters, M.; Kierkels, R.G.J.; Scandurra, D.; Both, S.; Steenbakkers, R.J.H.M.; Langendijk, J.A. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0574: Experience with Dutch National Indication Protocol_v1 model-based selection of proton therapy in HNC. (November 2020) Authors: Tambas, M.; Van den Hoek, J.G.M.; Kierkels, R.G.J.; Scandurra, D.; Wolters, A.; Mulder, D.; Oldehinkel, E.; Meijer, T.W.H.; Both, S.; Steenbakkers, R.J.H.M.; Langendijk, J.A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0427: Optimization of preselection process in model-based selection for proton in head and neck cancer. (November 2020) Authors: Tambas, M.; Van den Hoek, J.G.M.; Kierkels, R.G.J.; Scandurra, D.; Wolters, A.; Mulder, D.; Oldehinkel, E.; Meijer, T.W.H.; Both, S.; Steenbakkers, R.J.H.M.; Langendijk, J.A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PH-0328 Current practice for selection of adult patients for proton therapy across Europe. (August 2021) Authors: Tambas, M.; van der Laan, H.P.; Steenbakkers, R.; Doyen, J.; Timmermann, B.; Orlandi, E.; Hoyer, M.; Haustermans, K.; Georg, P.; Burnet, N.G.; Kirkby, K.; Gregoire, V.; Calugaru, V.; Troost, E.G.; Hoebers, F.; Calvo, F.A.; Widder, J.; Eberle, F.; van Vulpen, M.; Maingon, P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0750: Conventionally-fractionated VMAT vs. SBRT in prostate cancer:PSA kinetics, toxicity, quality of life. (April 2016) Authors: Tambas, M.; Agaoglu, F.; Iribas, A.; Guveli, M.; Dizdar, Y.; Okutan, M.; Ozkan, D.; Tenekeci, N.; Darendeliler, E. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗